| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
8sens.biognostic GmbH Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights
into a 8sens.biognostic GmbH's pipeline and investigational products. The
report also provides details on clinical trials covering trial phase,
description, investigator information, primary and secondary end-points and
trial results for products in development.
Scope
• Details of development stage by sector and equipment type.
• Pipeline
products grouped by therapy area, development stage and trial phase.
•
Detailed information on clinical trials covering trial phase, description,
investigator .nformation, primary and secondary end-points and trial
results.
• Trial updates, trial start and end dates, patient numbers and
the trials primary outcome measures, secondary outcome measures.
• Product
updates covering estimated approval dates and estimated launch dates.
•
Descriptions of novel technologies relating to pipeline products of the
company.
• Patents and patent applications covered for the product.
•
News updates on key events relating to the product and its development.
Reasons to buy
• A single source to fulfill competitor information relating to products in
development.
• Identify pipeline products that are potential competitor to
your product lines.
Understand a company's strategic position by accessing
detailed independent intelligence on its product pipeline.
• Access
clinical trial information to map trial results and plan targeted marketing
activities.
• Take corrective measures on your own development programs
and R&D initiatives based on regulatory events of competitor product
pipelines.
• Identification of potential investment opportunities.
•
Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets
you keep track of market potential build for a new product.
Assess a
company's future growth by determining its pipeline depth, for probable
acquisition opportunities.
TABLE OF CONTENTS
1 Table of Contents 3
1.1 List Of Tables 6
1.2 List of Figures 7
2
Company Overview 8
2.1 Key Information 8
2.2 Industry Outlook -- In
Vitro Diagnostics 8
3 Major Products and Services 9
3.1 Overview 9
4 Competitors 10
5 Key Employees 11
6 Locations And Subsidiaries
12
6.1 Head Office 12
7 8sens.biognostic GmbH Pipeline Products 13
7.1 8sens.biognostic GmbH Product Pipeline Analysis 13
7.1.1
8sens.biognostic GmbH Pipeline Products By Equipment Type 13
7.1.2
8sens.biognostic GmbH Pipeline Products By Development Stage 15
7.1.3
8sens.biognostic GmbH Pipeline Products By Therapy Area 16
7.2 ELISA test
for EBV IgA 16
7.2.1 Product Description 16
7.2.2 Product Status
16
7.3 Rapid test for CRP (barcode style) 17
7.3.1 Product Description
17
7.3.2 Product Status 17
7.4 Rapid test for MPO (barcode style)
17
7.4.1 Product Description 18
7.4.2 Product Status 18
7.5 Rapid
test for cTnI 18
7.5.1 Product Description 18
7.5.2 Product Status
19
7.6 Rapid test for Neopterin 19
7.6.1 Product Description 19
7.6.2 Product Status 19
7.7 ELISA test for HbsAg 20
7.7.1 Product
Description 20
7.7.2 Product Status 20
7.8 ELISA test for HbsAb 20
7.8.1 Product Description 20
7.8.2 Product Status 21
7.9 ELISA test
for HbeAb 21
7.9.1 Product Description 21
7.9.2 Product Status 22
7.10 ELISA test for HbcAb 22
7.10.1 Product Description 22
7.10.2
Product Status 22
7.11 ELISA test for HCV 23
7.11.1 Product
Description 23
7.11.2 Product Status 23
7.12 CRP-Test Reader 23
7.12.1 Product Description 23
7.12.2 Product Status 24
7.13 MacroDot
Arrays 24
7.13.1 Product Description 24
7.13.2 Product Status 24
8
Appendix 25
8.1 Methodology 25
8.1.1 Coverage 25
8.1.2 Secondary
Research 26
8.1.3 Primary Research 26
8.1.4 Expert Panel Validation
27
8.2 Contact Us 27
8.3 About Global Markets Direct 27
8.4
Disclaimer 27
1.1 List Of Tables
Table 1: 8sens.biognostic
GmbH,Key Facts 8
Table 2: 8sens.biognostic GmbH, Key Employees,
11
Table 3: 8sens.biognostic GmbH Pipeline Products by Equipment Type
14
Table 4: 8sens.biognostic GmbH Pipeline Products By Development
Stage 15
Table 5: 8sens.biognostic GmbH Pipeline Products By Therapy
Area 16
1.2 List of Figures
Figure 1: 8sens.biognostic GmbH
Pipeline Products By Equipment Type 13
Figure 2: 8sens.biognostic
GmbH Pipeline Products By Equipment Type 14
Figure 3:
8sens.biognostic GmbH Pipeline Products By Development Stage 15
Figure 4:
Global Markets Direct Methodology 25
|
